Zongyi Hu

Jiangxi University of Technology — China

Medicine · Health Sciences

38h-index4.9kcitations73works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(32), Hepatitis B Virus Studies(27), Liver physiology and pathology(14), Liver Disease Diagnosis and Treatment(9), Pancreatic function and diabetes(8)

Publications73 total

Life’s Crucial 9 Score as a Novel Role for Chronic Obstructive Pulmonary Disease Screening
International Journal of COPD·2025Open Access
Paeoniflorin Alleviates Lipopolysaccharide-Induced Neuroinflammation and Depression Through the Keap1/Nrf2/HO-1 Signaling Pathway
Antioxidants·2025· 2 citedOpen Access
Moderating role of live microbe between chronic inflammatory airway disease and depressive symptoms
Frontiers in Nutrition·2025· 1 citedOpen Access
On a deep analysis of the reference time of multi-GNSS final and real-time precise clock products with respect to UTC
Measurement Science and Technology·2025· 1 cited
Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection
JCI Insight·2024· 1 citedOpen Access
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype
Communications Biology·2023· 41 citedOpen Access
Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis
Journal of Virology·2022· 2 citedOpen Access
A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells
Molecular Therapy — Nucleic Acids·2022· 19 citedOpen Access
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors
mBio·2022· 14 citedOpen Access
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
ACS Medicinal Chemistry Letters·2021· 22 citedOpen Access
Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells
Hepatology·2021· 68 citedOpen Access
Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly
Journal of Medicinal Chemistry·2021· 6 citedOpen Access
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
UNC Libraries·2020Open Access
Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion
Nature Microbiology·2020· 12 citedOpen Access
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
Cell chemical biology·2020· 24 citedOpen Access
Changes in Allergenicity of Ovalbumin <i>in Vitro</i> and <i>in Vivo</i> on Conjugation with Quercetin
Journal of Agricultural and Food Chemistry·2020· 86 citedOpen Access
Stem Cells and Liver Diseases
Stem Cells International·2019· 3 citedOpen Access
Discovery and Characterization of a Novel HCV Inhibitor Targeting the Late Stage of HCV Life Cycle
Antiviral Therapy·2018· 5 citedOpen Access
Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
The Journal of Infectious Diseases·2018· 13 citedOpen Access
Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, China
Epidemiology and Infection·2017· 4 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

T. Jake Liang(22), Ritva P. Evarts(13), E R Marsden(13), Snorri S. Thorgeirsson(11), Xin Hu(9), Kozo Fujio(8), T. Jake Liang(7), Wei Zheng(7), Noel Southall(6), Billy Lin(5), Zhensheng Zhang(5), Seung Bum Park(5), Qisheng Li(4), Shanshan He(4), Marc Ferrer(4), Juan Marugán(4), Madeleine Leek(4), Julie E. Ledgerwood(3), Galina V. Yamshchikov(3), LaSonji A. Holman(3)